Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1935)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2022 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Long XY, Zhang S, Tang LS, Li X, Liu JY. Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature. World J Clin Cases 2022; 10(33): 12305-12312 [PMID: 36483823 DOI: 10.12998/wjcc.v10.i33.12305] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i33/12305.htm |
| Number | Citing Articles |
| 1 |
Sakkarn Sangkhamanon, Natcha Kotano, Wichien Sirithanaphol, Ukrit Rompsaithong, Pakorn Kiatsopit, Aumkhae Sookprasert, Kosin Wirasorn, Prin Twinprai, Piyakarn Watcharenwong, Jarin Chindaprasirt. Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer. Biomedical Reports 2023; 19(1) doi: 10.3892/br.2023.1627
|
| 2 |
Cisplatin/paclitaxel/tislelizumab. Reactions Weekly 2023; 1945(1): 173 doi: 10.1007/s40278-023-34254-5
|